CSL stock: CSL maintains USD 2.92 dividend for CSL stock

Published on 10/21/2026 at 16:03 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS

FY 2026 underlying NPATA fell 2 percent to USD 3.10 billion. CSL stock costs EUR 121.55 on October 21, 2026 at 3:58 p.m. CEST.

Dividend and earnings snapshot

CSL maintained a USD 2.92 dividend on September 30, 2026.
Fiscal year 2026 underlying NPATA fell 2 percent to USD 3.10 billion.
CSL stock costs EUR 121.55 at Lang & Schwarz on October 21, 2026 at 3:58 p.m. CEST.
CSL's 2026 annual meeting is scheduled for October 27, 2026.

CSL, AU000000CSL8, Illustration mit AI erstellt.

CSL Limited (ISIN AU000000CSL8) maintained a USD 2.92 dividend for fiscal year 2026, a decision discussed by The Bull on September 30, 2026. The stock was trading at EUR 121.55 at Lang & Schwarz on October 21, 2026 at 3:58 p.m. CEST.

Dividend meets a weaker result

The payout provides a concrete income marker after CSL reported a difficult fiscal year. The company generated USD 15.8 billion of revenue in fiscal year 2026, down 1 percent on a constant-currency basis, while underlying NPATA fell 2 percent to USD 3.1 billion.

Yahoo Finance reported the fiscal 2026 results presentation's figures on October 13, 2026. Gross profit reached USD 8.5 billion, down 2 percent, while the group operating result was USD 6.8 billion, down 3 percent. The figures show that the maintained dividend sits alongside pressure on profitability rather than a stronger earnings base.

Stock stays below its yearly high

CSL's Australian quote was AUD 196.08 on October 21, 2026, with a market capitalization of AUD 94.1 billion and a 52-week range of AUD 90.00 to AUD 221.76. The Australian price stood 11.58 percent below its 52-week high, leaving the annual range as a useful measure of how far the recovery still has to run.

The Lang & Schwarz euro quotation converts to a level within that Australian range when viewed through the exchange rate, while the two listings remain separate price references. CSL operates in healthcare biotechnology and is listed on the Australian Securities Exchange under the ticker CSL.

Next date is October 27

CSL's 2026 annual general meeting is scheduled for October 27, 2026, according to the company's investor-relations page at CSL. The meeting gives shareholders a dated point for management commentary after the fiscal 2026 reset year and before the next full-year reporting cycle.

What the figures mean for CSL

The combination of a USD 2.92 dividend, USD 15.8 billion revenue and USD 3.1 billion underlying NPATA puts cash returns beside a lower profit base. For investors, the next material test is whether earnings can stabilize while CSL remains 11.58 percent below its 52-week high.

Euro price and investor context

CSL stock was trading at EUR 121.55 at Lang & Schwarz on October 21, 2026 at 3:58 p.m. CEST. The further course of trading is shown by the continuously updated real-time quote of CSL stock.